Status:
UNKNOWN
The Real World Study of Apatinib for Gastric Cancer Treatment in Anhui Province
Lead Sponsor:
The First Affiliated Hospital of Anhui Medical University
Conditions:
Gastric Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The investigators conduct the real world study to explore the efficacy and safety of Apatinib in gastric cancer .
Eligibility Criteria
Inclusion
- Male or female patients .
- Confirmed by Pathology or histology of Gastric cancer
- Patients should be voluntary to the trial and provide with signed informed consent
- The researchers believe patients can benefit from the study.
Exclusion
- Patients with a known history of allergic reactions and/or hypersensitivity attributed to apatinib or its accessories
- Pregnant or lactating women
- Patients with Apatinib contraindications
- Patients of doctors considered unsuitable for the trial
Key Trial Info
Start Date :
September 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2020
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03333967
Start Date
September 1 2017
End Date
September 1 2020
Last Update
November 7 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China, 230000